Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis
Authors
Keywords
Angiogenesis, Angiotensin-II, Non-alcoholic steatohepatitis, Hepatocarcinogenesis, Sorafenib
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 49, Issue 10, Pages 1421-1429
Publisher
Springer Nature
Online
2013-11-07
DOI
10.1007/s00535-013-0906-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
- (2012) Farbod Shojaei CANCER LETTERS
- Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress
- (2012) K. Kaji et al. CURRENT MEDICINAL CHEMISTRY
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
- (2012) Kohichiroh Yasui et al. HEPATOLOGY RESEARCH
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
- (2010) Yu-Xiong Feng et al. HEPATOLOGY
- Effect of sorafenib on murine liver regeneration
- (2010) Caroline Hora et al. HEPATOLOGY
- New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
- (2010) Yan Wang et al. JOURNAL OF HEPATOLOGY
- Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
- (2010) Claudia Paternostro WORLD JOURNAL OF GASTROENTEROLOGY
- Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
- (2009) N. S. Azad et al. CLINICAL CANCER RESEARCH
- Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
- (2009) Thomas Reiberger et al. JOURNAL OF HEPATOLOGY
- Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
- (2009) Hitoshi Yoshiji et al. JOURNAL OF HEPATOLOGY
- Targeting vessels to treat hepatocellular carcinoma
- (2008) Pamela Romanque et al. CLINICAL SCIENCE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model
- (2008) Tatsuhiro Tsujimoto et al. WORLD JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started